NASDAQ · HYPRHealthcareElectromedical Equipment

Hyperfine financials

$0.8050−3.70%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$13.6M$12.9M$11.0M$6.8M$1.5M
Gross profit$6.8M$5.9M$4.8M$907.0K-$1.2M
Gross margin49.8%45.7%43.1%13.3%−78.0%
Operating income-$37.1M-$43.2M-$48.1M-$73.9M-$64.9M
Net income-$35.6M-$40.7M-$44.2M-$73.2M-$64.9M
Net margin−262.3%−315.9%−401.0%−1073.7%−4335.0%
Diluted EPS$-0.43$-0.56$-0.62$-1.04$-17.57
EBITDA-$36.0M-$42.2M-$47.1M-$72.9M-$64.1M
Operating cash flow-$27.9M-$38.8M-$41.8M-$72.3M-$47.2M
Free cash flow-$29.1M-$39.1M-$42.6M-$72.9M-$49.9M
Diluted shares81.8M72.4M71.3M70.4M3.7M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$35.1M$37.6M$75.2M$117.5M$188.5M
Short-term investments$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$0.00$0.00$0.00
Total assets$55.3M$58.9M$94.2M$134.1M$202.5M
Total liabilities$14.3M$9.9M$9.8M$10.3M$16.2M
Shareholders' equity$41.0M$49.0M$84.4M$123.7M$186.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology